Improved survival using intensity-modulated radiation therapy in head and neck cancers: a SEER-Medicare analysis (Q44873720)

7 December 2017

Improved survival using intensity-modulated radiation therapy in head and neck cancers: a SEER-Medicare analysis (English)

1 reference

7 December 2017

0 references

6

Adam S Garden

1 reference

7 December 2017

5

K Kian Ang

1 reference

7 December 2017

Beth M Beadle

1

1 reference

7 December 2017

Kai-Ping Liao

2

1 reference

7 December 2017

Linda S Elting

3

1 reference

7 December 2017

Thomas A Buchholz

4

1 reference

7 December 2017

B Ashleigh Guadagnolo

7

1 reference

7 December 2017

language of work or name

English

0 references

publication date

13 January 2014

1 reference

7 December 2017

1 reference

7 December 2017

120

1 reference

7 December 2017

702-710

1 reference

7 December 2017

5

1 reference

7 December 2017

Cancer statistics, 2013

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28372

Radiation-induced xerostomia in patients with head and neck cancer: pathogenesis, impact on quality of life, and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28372

Radiation-induced xerostomia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28372

Quality of life and oral function in patients treated with radiation therapy for head and neck cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28372

Impact of late treatment-related toxicity on quality of life among patients with head and neck cancer treated with radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28372

Evaluation of trends in the use of intensity-modulated radiotherapy for head and neck cancer from 2000 through 2005: socioeconomic disparity and geographic variation in a large population-based cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28372

Prospective randomized study of intensity-modulated radiotherapy on salivary gland function in early-stage nasopharyngeal carcinoma patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28372

Impact of intensity-modulated radiotherapy on health-related quality of life for head and neck cancer patients: matched-pair comparison with conventional radiotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28372

Intensity-modulated radiotherapy versus conventional and 3D conformal radiotherapy in patients with head and neck cancer: is there a worthwhile quality of life gain?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28372

Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28372

Multi-institutional trial of accelerated hypofractionated intensity-modulated radiation therapy for early-stage oropharyngeal cancer (RTOG 00-22).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28372

Patterns of Care and Outcomes Associated With Intensity-Modulated Radiation Therapy Versus Conventional Radiation Therapy for Older Patients With Head-and-Neck Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28372

Assessing the utility of cancer-registry-processed cause of death in calculating cancer-specific survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28372

A new method of classifying prognostic comorbidity in longitudinal studies: development and validation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28372

Data sources for measuring comorbidity: a comparison of hospital records and medicare claims for cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28372

A refined comorbidity measurement algorithm for claims-based studies of breast, prostate, colorectal, and lung cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28372

Development of a comorbidity index using physician claims data

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28372

Some methods of propensity-score matching had superior performance to others: results of an empirical investigation and Monte Carlo simulations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28372

Two-stage residual inclusion estimation: addressing endogeneity in health econometric modeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28372

The use of linear instrumental variables methods in health services research and health economics: a cautionary note

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28372

Disease-control rates following intensity-modulated radiation therapy for small primary oropharyngeal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28372

Intensity-modulated radiotherapy in the treatment of oropharyngeal cancer: clinical outcomes and patterns of failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28372

Intensity-modulated radiation therapy in oropharyngeal carcinoma: effect of tumor volume on clinical outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28372

Comparative effectiveness of prostate cancer treatments: evaluating statistical adjustments for confounding in observational data.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28372

Long-term survival following partial vs radical nephrectomy among older patients with early-stage kidney cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28372

Cost-effectiveness of intensity-modulated radiotherapy in oropharyngeal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28372

Xerostomia and its predictors following parotid-sparing irradiation of head-and-neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28372

7 January 2021

Predictors of IMRT and conformal radiotherapy use in head and neck squamous cell carcinoma: a SEER-Medicare analysis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28372

7 January 2021

Xerostomia and quality of life after intensity-modulated radiotherapy vs. conventional radiotherapy for early-stage nasopharyngeal carcinoma: initial report on a randomized controlled clinical trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28372

7 January 2021

Three-dimensional conformal radiotherapy (3D-CRT) versus intensity modulated radiation therapy (IMRT) in squamous cell carcinoma of the head and neck: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28372

7 January 2021

Risk factors and dose-effect relationship for mandibular osteoradionecrosis in oral and oropharyngeal cancer patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28372

7 January 2021

Identifiers

DOI

10.1002/CNCR.28372

1 reference

7 December 2017

1 reference